We deliver tailored insights in the natural and social sciences through white papers, reports, executive summaries, and visual presentations. Our work ranges from comprehensive state-of-the-art reviews that clarify complex issues, to highly targeted analyses that address niche challenges, address stakeholder needs, and accelerate economic or organizational goals.
Analysis of critical challenges, including environmental exposures, cumulative chemical and non-chemical stressors, and issues of food safety and security.
Evaluation of both treatment advances and threats related to emerging zoonotic diseases to epidemic and pandemic risks (e.g., Chikungunya virus, Zika virus, West Nile virus, SARS-CoV–2).
Insights into breakthroughs in diagnosis and treatment of hereditary and chronic diseases (e.g., diabetes, heart disease), autoimmune and deficiency disorders, and cancer.
Assessment of transformative trends such as generative AI and quantum computing, and their potential disruptions for science, business, and society.
Examination of advances and challenges in agriculture, water quality, resource resilience, and disaster management.
Linking clients to innovators and providing timely analysis of local, state, and federal programs driving enterprise and economic development.
Research on social and economic disparities, with an emphasis on inequities in education, housing, healthcare, and access to research opportunities.
Strategic analysis of disruptions, risks, and potential opportunities linked to a changing climate.
Our consulting model combines deep scientific expertise with trusted networks across academia, government, and industry. We assemble the right experts for your project and guide the process from start to finish, ensuring transparency, rigor, and results that directly support your needs and objectives.
At The Veles Group, we are committed to helping our clients understand and navigate both the opportunities and challenges of generative artificial intelligence (genAI). We can provide evidence-based guidance on implementing genAI effectively—and on how this technology may impact your organization, stakeholders, or constituents.
Generative AI is a powerful tool, but it comes with well-documented logical, legal, ethical, and regulatory risks. For this reason, The Veles Group does not use genAI to generate deliverables for clients. While the technology is impressive, it cannot replace human expertise, context, and innovation. In fact, genAI is prone to significant challenges, including:
Every product we deliver is crafted and reviewed by scientific experts in their respective fields, then undergoes additional quality assurance by The Veles Group to ensure it meets the highest professional standards. Our clients can rely on us for information and recommendations that are unbiased, evidence-based, and rigorously validated.
While we do not use genAI to produce client deliverables, The Veles Group may responsibly apply the technology for limited purposes such as editing and formatting documents, or enhancing visuals created by our experts. We continually monitor the evolution of genAI technologies and will adapt our policies as needed—always guided by the strongest ethical, legal, security, and scientific standards.
